The pharmaceutical processing seals market is projected to grow from USD 2.1 billion in 2021 to USD 3.3 billion by 2026, at a CAGR of 10.0% during the forecast period. The favorable rules and regulations for pharmaceutical manufacturing in the developing regions such as APAC, the Middle East & Africa, and South America are expected to drive the pharmaceutical processing seals market. The consumption of pharmaceutical drugs is rapidly increasing at the global level especially, in the rapidly growing economies in APAC. In order to cater to the increasing demand for pharmaceutical drugs, there is an increase in the investments made in the pharmaceutical manufacturing equipment industry for capacity expansions and R&D activities. Expansion of the healthcare sector due to increasing population and improved awareness about quality healthcare are expected to drive the pharmaceutical industry and thus, boost the demand for pharmaceutical processing seals, globally.
There are various types of pharmaceutical processing seals available in the market, namely, O-rings, gaskets, lip seals, and D seals. These seals are available in different grades, shapes, and sizes. The O-rings segment dominated the pharmaceutical processing seals market owing to its high demand in pharmaceutical manufacturing equipment. O-rings are used in pharmaceutical industry for applications such as cryogenic, bioprocessing, cleaning, and sterilization. These seals are used in pharmaceutical industry in agitators and hydraulic cylinders. The reason for the growth of the O-rings segment is its cost-effectiveness and wide range of applications.
Trelleborg AB (Sweden), Freudenberg Group (Germany), Flowserve Corporation (US), James Walker (UK), Parker Hannifin Corporation (US), Saint-Gobain S.A. (France), Garlock (US), John Crane (US), IDEX Corporation (US), and Morgan Advanced Materials PLC (UK) are the leading players operating in the pharmaceutical processing seals market.
